RecruitingNCT07574645

Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry

SPIDER - Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry


Sponsor

Thomas Jefferson University

Enrollment

1,000 participants

Start Date

Jan 5, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with spinal dural arteriovenous fistula. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07574645